Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/05/2003US20030105162 Method for treating bronchial constriction and bronchospasm
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105159 Kavalactone compositions and methods of use
06/05/2003US20030105158 Hydrates of a neuraminic acid compound and crystalline forms thereof
06/05/2003US20030105157 Aqueous solution of ascorbic acid and method for producing same
06/05/2003US20030105155 Prostanoic acid derivatives as agents for lowering intraocular pressure
06/05/2003US20030105154 Therapy for vascular diseases; anticholesterol agents; antidiabetic agents, cardiovascular disorders
06/05/2003US20030105152 Treatments for neurotoxicity in Alzheimer's disease
06/05/2003US20030105151 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105149 Enhancement of learning and memory and treatment of amnesia
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105145 Polysubstituted indan-1-ol compounds, and methods for their preparation and use
06/05/2003US20030105144 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics
06/05/2003US20030105143 Bactericides, antiseptics, cosmetics, cleaning compounds, enhaned oil recovery, papermaking
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105141 Mixture containing fatty acid and aromatic amine; administering by mouth; cyclooxygenase enzyme inhibitor
06/05/2003US20030105140 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
06/05/2003US20030105139 Indole derivatives as 5-HT receptor antagonist
06/05/2003US20030105138 Using carvedilol, or synergistic mixture thereof
06/05/2003US20030105135 Adrenergic receptors; gastrointestinal disorders, dietetics, urogenital disorders, antidiabetic agents
06/05/2003US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
06/05/2003US20030105129 Chemical compounds
06/05/2003US20030105128 Treatment of sexual dysfunction in certain patient groups
06/05/2003US20030105127 Contacting fluoroquinolone resistant pathogenic bacteria with an antibacterially effective amount of gemifloxacin compound, or antibacterially effective derivatives thereof
06/05/2003US20030105126 Irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
06/05/2003US20030105125 Tropane analogs and methods for inhibition of monoamine transport
06/05/2003US20030105124 Substituted benzolactam compounds
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105122 Compounds for enhancing chemotherapy
06/05/2003US20030105121 Method of preventing lipodystrophy syndrome or reversing a pre-existing syndrome in HIV-infected patients being treated with antiretroviral agents
06/05/2003US20030105120 Orally administered analgesic compositions containing nalbuphine
06/05/2003US20030105119 For therapy of inflammation, immune disorders, asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis (MS), inflammatory bowel disease (IBD); side effect reduction
06/05/2003US20030105116 Fused tri-heterocyclic compounds
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105113 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl ] piperazine
06/05/2003US20030105112 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/05/2003US20030105110 Novel compounds
06/05/2003US20030105109 New campothecin analogue compounds
06/05/2003US20030105108 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105105 As anticoagulant agents for therapy and prophylaxis of thromboembolic disorders
06/05/2003US20030105104 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
06/05/2003US20030105101 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105096 Serotonin transport inhibitors
06/05/2003US20030105095 4'-Methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105093 MTP activity-lowering compositions
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105089 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
06/05/2003US20030105088 Thiol-based NAALADase inhibitors
06/05/2003US20030105087 New polycyclic azaindole compounds
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003US20030105083 Drug combination for the treatment of depression and related disorders comprising mirtazapine
06/05/2003US20030105081 Heterocyclic compounds as ligands of the GABAA receptor
06/05/2003US20030105080 Thienylalanine derivatives as inhibitors of cell adhesion
06/05/2003US20030105079 Novel phenylalkyl diamine and amide analogs
06/05/2003US20030105075 Hymenialdisine or derivatives thereof in the manufacture of medicaments
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/05/2003US20030105069 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
06/05/2003US20030105068 Organometallic complex
06/05/2003US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments
06/05/2003US20030105063 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
06/05/2003US20030105062 Anti-bacterial agents based upon oxoanion binding
06/05/2003US20030105061 For use in resecting epithelium
06/05/2003US20030105060 Synthetic oligomannosides, preparation and uses thereof
06/05/2003US20030105052 Oligoribonucleotide derivatives for specific inhibition of gene expression
06/05/2003US20030105050 Disorders caused by overproduction of collagen fibres, for example, liver cirrhosis, kidney, liver and heart fibrosis, scleroderma, hypertrophic scars and keloids
06/05/2003US20030105034 For suppression of hypersensitivity and inflammatory reactions such as dermatological disorders
06/05/2003US20030105033 Administering Compound E5564 for therapy of endotoxemia, sepsis, and septic shock
06/05/2003US20030105032 Administering compound selected from MonoPhosphoryl Lipid A (MPL) and Serinol Aminoalkyl Glucosaminide Phosphate compound (AGP) for prophylaxis and therapy of infectious disease, autoimmune disease or allergic condition
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105030 Method and compositions for regulation of 5-alpha reductase activity
06/05/2003US20030105029 Drugs, foods or drinks with the use of algae-derived physiologically active substances
06/05/2003US20030105028 Substituted 2-azetidinones useful as hypocholesterolemic agents
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030105014 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
06/05/2003US20030105006 For therapy of bacterial infections
06/05/2003US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104985 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates
06/05/2003US20030104980 Treating sexual desire disorders with flibanserin
06/05/2003US20030104976 Analgesic methods using endothelin receptor ligands
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104970 Modulating the growth state of an epithelial cell by ectopically contacting the epithelial cell, in vitro or in vivo, with hedgehog polypeptide or patched therapeutic to promote or inhibit of proliferation of epithelial cell
06/05/2003US20030104620 Expression vector for expression of heterologous polypeptides and amplification of cell viral resistance; viricides
06/05/2003US20030104606 Biosensor for detection of vibrio luminescent protein; biological pest control; bactericides; gene expression inhibition
06/05/2003US20030104596 human desaturase gene and uses thereof
06/05/2003US20030104582 Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
06/05/2003US20030104578 Secreted in yeast; storage stability; microbiocides
06/05/2003US20030104576 Methylation inhibitors; vaccines; viricides
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104528 Lymphocytes; transcription factors; interferons
1 ... 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5465 ... 7860